Coronavirus COVID-19 FAQs
Please continue to refer to this page and the latest official advice and guidance from the Ministry of Health (MOH), Higher Education Council (HEC) and other government entities.
Anyone who experiences symptoms of the Coronavirus (COVID-19) or may have been in contact with a person who has the Coronavirus (COVID-19) is advised to contact the Hotline (444).
Yes. If you are sharing your home with others, you should stay in a different room from other people or be separated as much as possible. Wear a surgical mask when you are in the same room as another person, and when seeking medical care. Use a separate bathroom, if available.
Make sure that you do not share a room with people who are at risk of severe disease, such as elderly people and those who have heart, lung or kidney conditions, and diabetes.
Visitors who do not have an essential need to be in the home should not visit while you are isolating.
The health and safety of our students remains our priority, therefore RCSI Bahrain has invested in increasing the level of general cleaning completed on campus.
Extra measures we have put in place are as follows (this list is not inclusive):
- An Isolation Room has been designated and prepared for any person who experiences any symptoms of COVID-19 while on-campus.
- We have arranged for frequently touched surfaces, such as door handles, light switches, handrails etc. to be cleaned at increased frequency
- Welfare facilities and communal areas will also be cleaned more frequently.
- Each room, office, laboratory, tutorial room and communal area will be provided with cleaning materials to keep the environment hygienically clean and we are advised to regularly clean any personal items brought in from home.
- In addition to the scheduled cleaning and disinfection that would be carried out by the soft services team, everyone will be expected to clean their own stations daily and more importantly to “clean as you go” when moving around on campus to maintain the hygiene standards needed to kill any virus particles.
Passengers are advised to check with their airlines to confirm the status of their flights in advance.
Entry into Bahrain remains restricted to nationals, residents and visa holders. Please liaise with Student Services for visa renewal on firstname.lastname@example.org.
All arriving passengers will be routed through the airport as per their travel histories, countries of travel origin and any symptoms reported. They will then be taken to designated areas of the airport for mandatory clinical examinations, which takes a minimum of two hours after arrival. All passengers arriving in Bahrain will be tested for COVID-19.
As per revised entry procedures, starting from Monday 22 February 2021 all arriving passengers must abide by the following:
- First mandatory COVID-19 testing will be performed upon arrival.
- Download and activate the “BeAware Bahrain” application and self-isolate until a test result is issued following the on-arrival testing.
- Second COVID-19 test is to be performed 5 days after the arrival date.
- Third COVID-19 test is to be performed 10 days after the arrival date.
Please note that the total fee for the three COVID-19 tests will be reduced to BD36.
If a COVID-19 test result is positive, passengers/citizens/residents will be advised of further courses of action by the Ministry of Health (MoH) staff. Passengers will also be followed up with by the Ministry of Health.
- If you travelled outside Bahrain over the past month, please notify us by email and enroll with the Medical Examination Registration Service.
- If you are unwell in Bahrain with cough, fever, difficulty breathing, please stay at home, call 444 and follow instructions provided.
- For students, please liaise with your SARA coordinator or the Student Health and Wellbeing Centre.
- For staff, please liaise with HR.
- For more information on Bahrain International Airport, please click here.
For international students, we understand these are very difficult times to be away from friends and family at home. While we acknowledge that it is each student’s personal decision as to whether or not you choose to travel overseas during the year, we would like to remind you that the university advises against all unnecessary travel.
RCSI Bahrain strongly advises our SC2 students not to travel internationally this academic year.
With the current international travel situation rapidly evolving, and ongoing requirements to restrict movement upon arrival in many home countries applying, we believe the safest thing to do in terms of protecting human health, as well as minimizing risks to your academic progression, is not to travel overseas unless absolutely necessary.
There are also cost implications to be aware of, such as flight cancellations, COVID-19 testing fees, and quarantine regulations in different countries. Please also do not endanger yourself – or your family, friends, fellow students, staff and particularly patients- who will trust you to keep your commitments to public safety.
If you do decide to travel and cannot return to Bahrain on time, we may not be able to provide you with adequate catch-up for required clinical placement and this of course will impact your ability to successfully complete the academic year 20-21. We greatly appreciate that students will have to make a difficult choice not to travel, in the interests of the wider collective public health. RCSI Bahrain will work hard to support you over this time.
This situation is evolving, and staff and students should continue to regularly check the RCSI Bahrain FAQ page along with the following online resources:
For more information on how Bahrain is battling COVID-19 please download the following documents
RCSI Bahrain Contribution to COVID-19 Clinical Trials
RCSI Bahrain has been honourably nominated to support the COVID-19 clinical trials in Bahrain under the direction of Professor Stephen Atkin, Head of School of Postgraduate Research.
With the aim to enhance the treatment protocols for COVID-19 patients in Bahrain and beyond, RCSI Bahrain sponsored the National Convalescent Plasma Clinical Trial in COVID-19 patients, in collaboration with the Bahrain Defence Force Hospital (BDF) and the Ministry of Health. This initiative comes under the directives from the Supreme Council of Health (SCH) President and taskforce head, His Excellency Lieutenant General Dr Shaikh Mohammed bin Abdulla Al Khalifa.
The clinical trial, which is being conducted in three centres around Bahrain, entails taking antibody-rich plasma that has been given by subjects that have recovered from COVID-19 and injecting it into patients who are severely suffering from the disease. Patients who have contracted COVID-19 and require oxygen therapy will be randomised to either the plasma treatment with supporting care, or normal supporting care, both of which will include drug treatment against the virus.